These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38512126)

  • 21. Exploring Neural Efficiency in Multiple Sclerosis Patients during the Symbol Digit Modalities Test: A Functional Magnetic Resonance Imaging Study.
    Fittipaldi-Márquez MS; Cruz-Gómez ÁJ; Sanchis-Segura C; Belenguer A; Ávila C; Forn C
    Neurodegener Dis; 2017; 17(4-5):199-207. PubMed ID: 28538226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuropsychological and MRI diagnostics in secondary progressive multiple sclerosis].
    Penner IK; Gass A; Schreiber H; Wattjes MP
    Nervenarzt; 2021 Dec; 92(12):1293-1301. PubMed ID: 33891150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deconstructing the symbol digit modalities test in multiple sclerosis: The role of memory.
    Patel VP; Walker LAS; Feinstein A
    Mult Scler Relat Disord; 2017 Oct; 17():184-189. PubMed ID: 29055455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS.
    Marstrand L; Østerberg O; Walsted T; Skov AC; Schreiber KI; Sellebjerg F
    Mult Scler Relat Disord; 2020 Jan; 37():101458. PubMed ID: 31683230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Verbal fluency deficits in multiple sclerosis.
    Henry JD; Beatty WW
    Neuropsychologia; 2006; 44(7):1166-74. PubMed ID: 16293271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Siponimod and Cognition in Secondary Progressive Multiple Sclerosis: EXPAND Secondary Analyses.
    Benedict RHB; Tomic D; Cree BA; Fox R; Giovannoni G; Bar-Or A; Gold R; Vermersch P; Pohlmann H; Wright I; Karlsson G; Dahlke F; Wolf C; Kappos L
    Neurology; 2021 Jan; 96(3):e376-e386. PubMed ID: 33328324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
    Van Schependom J; D'hooghe MB; Cleynhens K; D'hooge M; Haelewyck MC; De Keyser J; Nagels G
    Eur J Neurol; 2014 Sep; 21(9):1219-25, e71-2. PubMed ID: 24850580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
    Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practice effect in Symbol Digit Modalities Test in multiple sclerosis patients treated with natalizumab.
    Roar M; Illes Z; Sejbaek T
    Mult Scler Relat Disord; 2016 Nov; 10():116-122. PubMed ID: 27919477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidental learning during rapid information processing on the symbol-digit modalities test.
    Denney DR; Hughes AJ; Elliott JK; Roth AK; Lynch SG
    Arch Clin Neuropsychol; 2015 Jun; 30(4):322-8. PubMed ID: 25857404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The computer-based Symbol Digit Modalities Test: establishing age-expected performance in healthy controls and evaluation of pediatric MS patients.
    Bigi S; Marrie RA; Till C; Yeh EA; Akbar N; Feinstein A; Banwell BL
    Neurol Sci; 2017 Apr; 38(4):635-642. PubMed ID: 28078569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishing the consistency of a voice recognition symbol digit modalities test analogue.
    Wishart M; Everest MR; Morrow SA; Rose J; Shen L; Feinstein A
    Mult Scler; 2023 Nov; 29(13):1676-1679. PubMed ID: 37842762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume.
    Bisecco A; Stamenova S; Caiazzo G; d'Ambrosio A; Sacco R; Docimo R; Esposito S; Cirillo M; Esposito F; Bonavita S; Tedeschi G; Gallo A
    Brain Imaging Behav; 2018 Feb; 12(1):20-28. PubMed ID: 28083844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Rapid Electronic Cognitive Assessment Measure for Multiple Sclerosis: Validation of Cognitive Reaction, an Electronic Version of the Symbol Digit Modalities Test.
    Middleton RM; Pearson OR; Ingram G; Craig EM; Rodgers WJ; Downing-Wood H; Hill J; Tuite-Dalton K; Roberts C; Watson L; Ford DV; Nicholas R;
    J Med Internet Res; 2020 Sep; 22(9):e18234. PubMed ID: 32965240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a Tablet-based symbol digit modalities test for reliably assessing information processing speed in patients with stroke.
    Tung LC; Yu WH; Lin GH; Yu TY; Wu CT; Tsai CY; Chou W; Chen MH; Hsieh CL
    Disabil Rehabil; 2016 Sep; 38(19):1952-60. PubMed ID: 26860823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting Neuropsychological Impairment in Relapsing Remitting Multiple Sclerosis: The Role of Clinical Measures, Treatment, and Neuropsychiatry Symptoms.
    Lozano-Soto E; Cruz-López ÁJ; Gutiérrez R; González M; Sanmartino F; Rashid-Lopez R; Espinosa-Rosso R; Forero L; González-Rosa JJ
    Arch Clin Neuropsychol; 2021 May; 36(4):475-484. PubMed ID: 33067616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis.
    Rosenstein I; Axelsson M; Novakova L; Rasch S; Blennow K; Zetterberg H; Lycke J
    Front Immunol; 2023; 14():1106028. PubMed ID: 36742305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis.
    Lapshin H; Lanctôt KL; O'Connor P; Feinstein A
    Mult Scler; 2013 Dec; 19(14):1905-12. PubMed ID: 23652217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Working ability in individuals with different disease courses of multiple sclerosis: Factors beyond physical impairment.
    Renner A; Baetge SJ; Filser M; Penner IK
    Mult Scler Relat Disord; 2020 Nov; 46():102559. PubMed ID: 33035965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validity of a computerized version of the symbol digit modalities test in multiple sclerosis.
    Akbar N; Honarmand K; Kou N; Feinstein A
    J Neurol; 2011 Mar; 258(3):373-9. PubMed ID: 20924594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.